Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece. [PDF]
Perdrizet JE, Rozenbaum MH, Heffler MJ.
europepmc +1 more source
Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam. [PDF]
Ong DS+14 more
europepmc +1 more source
Prevention of Invasive Pneumococcal Disease Among Black or African American Children With and Without Sickle Cell Disease in the United States After Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2005 Through 2019. [PDF]
Payne AB+7 more
europepmc +1 more source
Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022. [PDF]
Grewal R+7 more
europepmc +1 more source
Assessing the Impact of Pneumococcal Conjugate Vaccines
openaire +2 more sources
Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study. [PDF]
Nasreen S+7 more
europepmc +1 more source
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions. [PDF]
Rozenbaum MH+11 more
europepmc +1 more source
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland. [PDF]
Alexandrova Nikolova K+3 more
europepmc +1 more source
Immunogenicity, Immunological Memory and Monitoring of Disease Activity Following an Anamnestic Immunization With the 13-Valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome. [PDF]
Kitsou K+8 more
europepmc +1 more source